Pregnancy category C: Controlled studies have been carried out neither in animals nor in pregnant women.
Because of possible anaphylactoid or anaphylactic reactions, the preparation should only be administered during pregnancy, if its expected benefits definitely outweigh possible risks.
It is not known whether Gelofusine passes into breast milk. Sufficient experience with application during breast-feeding period is not available.